Hepione Therapeutics Inc

Website
515 E 72nd St Apt 26G
New York, NY 10021

Hepione Therapeutics Inc. is a biotech startup based in New York City, specializing in the development of monoclonal antibodies aimed at preventing opioid overdoses, particularly from fentanyl. Utilizing their proprietary VAST platform, the company generates high-affinity antibodies that can effectively neutralize the toxic effects of small molecules associated with opioid use disorders.

Founded by a team of experienced scientists and business experts, Hepione is located within the BioLabs NYU Langone laboratories, part of a rapidly growing biotech cluster in Manhattan. The company is committed to addressing the ongoing U.S. overdose epidemic by partnering with leading pharmaceutical firms to tailor their innovative solutions to specific needs in the field.

Generated from the website

Own this business?
See a problem?

You might also like

United StatesNew YorkNew YorkHepione Therapeutics Inc

Partial Data by Infogroup (c) 2024. All rights reserved.